A DOWNPATRICK man has been appointed a partner at a major multinational law firm.
Michael Stewart has joined Pinsent Masons and will be based at the firm’s office Dublin.
Mr Stewart is a leading life sciences lawyer, specialising in corporate transactional projects including M&A, assets sales and purchases, corporate finance and licensing and collaboration deals.
He was formerly with Novartis, a global healthcare company based in Switzerland, where he was most recently lead counsel in the group transactions team.
Previously, he held roles as global head of legal strategic transactions and established medicines in the company’s pharmaceuticals division and senior counsel in the group M&A team.
Head of IP and Life Sciences at Pinsent Masons, Clare Tunstall said: “Michael has acted on some of the biggest transactions in the sector.
“His in-house and private practice expertise will have a significant impact on our multinational life sciences capabilities and in particular will enhance our on the ground sector overrun in Dublin.
“High growth biotech and medtech start-ups play a pivotal role in the pharmaceuticals industry and we are confident that Michael’s expertise will enable us to further tap into this vibrant market.”
During his time at Novartis, Mr Stewart worked on a number of major transactions.
Commenting on his move to Pinsent Masons, Mr Stewart said: “After seven years in-house I am very excited to move back to private practice and continue my career at Pinsent Masons.
“The firm’s reputation as a leader in life sciences legal services, its stellar client base and depth of expertise will be an excellent platform that will enable me to build a thriving cross-border practice.”